Regulatory Affairs: The IND, NDA, and Post-Marketing

Attend this virtual training course to learn about FDA regulations and expectations for the content, submission and review of INDs and NDAs, and the importance of regulatory strategy.

参加申し込み

戻る Agenda

Introduction to Regulation of Drugs and Biologics in the United States: Pre-Course Part Two

Session Chair(s)

Elliott Berger, PHD, MS

President

ETB Regulatory Consulting, United States

Introduction to Regulation of Drugs and Biologics in the United States: Pre-Course Part Two

参加申し込み

Regulatory Affairs: The IND, NDA, and Post-Marketing

Introduction to Regulation of Drugs and Biologics in the United States: Pre-Course Part Two

Session Chair(s)

Elliott Berger, PHD, MS

最新情報や機会を逃さないで